Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | TATVA Tatva Chintan Pharma Chem Limited Media · Small | WINDLAS Windlas Biotech Limited Pharma · Small | DRAGARWQ Dr Agarwals Eye Hospital Limited Pharma · Small | VIMTALABS Vimta Labs Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 23 | 46 | 54 | 46 |
| Verdict | OVERVALUED | FAIR VALUE | FAIR VALUE | FAIR VALUE |
| Style | OVERVALUED | Financial Turnaround | Financial Turnaround | Financial Turnaround |
| Piotroski | 7/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 1/30 | 10/30 | 5/30 | 3/30 |
| Growth | 5/25 | 12/25 | 21/25 | 17/25 |
| Quality | 0/20 | 2/20 | 14/20 | 8/20 |
| Balance Sheet | 11/15 | 13/15 | 5/15 | 9/15 |
| Cash Flow | 1/10 | 4/10 | 4/10 | 4/10 |
| Price | ₹1,160 | ₹835.4 | ₹4,989.7 | ₹527.85 |
| P/E | 63.40 | 25.30 | 34.40 | 38.70 |
| P/B | 3.41 | 2.96 | 6.96 | 6.83 |
| ROE | 5.53% | 12.20% | 25.20% | 13.50% |
| ROCE | 7.14% | 15.90% | 17.40% | 17.60% |
| Debt / Equity | 0.15 | 0.06 | 0.94 | 0.04 |
| FCF Yield | — | 0.77% | — | — |
| Dividend Y | 0.09% | 0.71% | 0.12% | 0.38% |
| Altman Z | 8.15 | 5.58 | 5.47 | 8.95 |
| Promoter % | 72.02% | 63.31% | 72.67% | 35.85% |
| Mkt Cap (₹Cr) | 2667.00 | 1680.00 | 2412.00 | 2354.00 |
| Graham # | ₹367.59 | ₹441.41 | ₹1,529.71 | ₹155.05 |
| Fair PE | 5.8 | 42.0 | 42.0 | 42.0 |
| MoS % | -1016.3% | +36.8% | +18.1% | +9.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startTATVA128
WINDLAS77
DRAGARWQ100
VIMTALABS76